#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant peritoneal neoplasm Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency C3 glomerulopathy Oesophageal adenocarcinoma stage III Rheumatoid arthritis Frontotemporal dementia High-grade B-cell lymphoma Congenital disorder of glycosylation Gaucher's disease type I Atypical haemolytic uraemic syndrome Cystic fibrosis gastrointestinal disease Meningitis meningococcal Extra-osseous Ewing's sarcoma metastatic Stress cardiomyopathy Cervix carcinoma More trials…

    Learn about Rare Diseases

    MELAS syndrome – Diagnostics Noonan syndrome – Life with Disease Mantle cell lymphoma stage III – Trials in Disease Sarcoidosis – Diagnostics Urea cycle disorder Mantle cell lymphoma – Treatment Nephroblastoma Osteosarcoma metastatic – Trials in Disease Marfan’s syndrome – Diagnostics Noonan syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aztreonam Sabestomig Imipramine Hydrochloride Sulfamethizole Pralatrexate VOROLANIB Amivantamab Bi 706321 Resmetirom Phenylephrine Etifoxine Hydrochloride Sorafenib Tosilate Dronedarone Nizatidine Mcla-129 Tofogliflozin SONLICROMANOL HYDROCHLORIDE At-1501 Dexamethasone Acetate Ph. Eur. NORELGESTROMIN More therapies…

    Learn about Your Condition

    Malignant neoplasm of choroid Lung transplant rejection Hot flush Dedifferentiated liposarcoma Glomerulonephritis membranous Fragile X syndrome Metastases to rectum Heart transplant Deafness Pertussis Indolent systemic mastocytosis Alport's syndrome Prodromal Alzheimer's disease Hypersensitivity Cardiac amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on AloCelyvir with Chemotherapy and Radiotherapy for Children and Adolescents with Relapsed or Refractory Extracranial Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
    Spain

  • Study of TranspoCART19 Infusion for Patients with Relapsed or Refractory B-cell Lymphoma Using Genetically Modified T Lymphocytes

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Transpocart19
    • Bendamustine Hydrochloride
    • Cetuximab
    Spain

  • Study on Amiodarone for Critically Ill Patients After Out-of-Hospital Cardiac Arrest with Shockable Rhythm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Amiodarone Hydrochloride
    France

  • Study of Pemigatinib for Patients with Recurrent or Metastatic Solid Tumors with FGFR Gene Alteration

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Pemigatinib
    France

  • Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Mecasermin Rinfabate
    Finland Germany Ireland Italy The Netherlands Portugal +1

  • Study on Treating Status Epilepticus in Seniors Using Levetiracetam and Valproate Semisodium

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Status epilepticus
    Investigated Drugs:
    • Valproate Semisodium
    • Levetiracetam
    Germany
Previous Page
1 … 608 609 610 611 612 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!